Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 4898064

Post-transplantation malignancy.

P M Lutterbeck
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Antilymphocyte SerumChildHumansKidney TransplantationLymphoma, Large B-Cell, DiffuseNeoplasm TransplantationTransplantation, HomologousJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P M Lutterbeck. 1969-09-25. Post-transplantation malignancy.. https://doi.org/10.1056/nejm196909252811319

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low-dose cyclophosphamide and anti-thymocyte globulin.

Bone marrow failure is the major cause of early mortality in patients with dyskeratosis congenita (DC); early trials with conventional conditioning regimens were associated with remarkable chronic morbidity and mortality, and the optimal conditioning regimen for these patients remains undetermined. We report a case of a child afflicted with DC who underwent related full HLA-matched stem cell transplant (SCT) using a regimen of low dose cyclophosphamide and antithymocyte globulin (ATG). The regimen was well tolerated and associated with no significant short-term toxicity.

Antilymphocyte Serum↗